Golden State Wealth Management LLC Invests $31,000 in Utah Medical Products, Inc. (NASDAQ:UTMD)

Golden State Wealth Management LLC acquired a new stake in Utah Medical Products, Inc. (NASDAQ:UTMD) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 500 shares of the medical instruments supplier’s stock, valued at approximately $31,000.

A number of other hedge funds have also made changes to their positions in UTMD. Hotchkis & Wiley Capital Management LLC lifted its position in Utah Medical Products by 128.3% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 89,010 shares of the medical instruments supplier’s stock worth $5,956,000 after purchasing an additional 50,030 shares during the period. Minerva Advisors LLC raised its stake in shares of Utah Medical Products by 461.8% in the 3rd quarter. Minerva Advisors LLC now owns 42,328 shares of the medical instruments supplier’s stock worth $2,818,000 after buying an additional 34,794 shares in the last quarter. Rice Hall James & Associates LLC lifted its holdings in shares of Utah Medical Products by 24.3% in the third quarter. Rice Hall James & Associates LLC now owns 83,338 shares of the medical instruments supplier’s stock valued at $5,576,000 after buying an additional 16,297 shares during the period. Victory Capital Management Inc. boosted its stake in Utah Medical Products by 439.0% during the third quarter. Victory Capital Management Inc. now owns 14,408 shares of the medical instruments supplier’s stock valued at $964,000 after buying an additional 11,735 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in Utah Medical Products by 9.6% during the third quarter. Geode Capital Management LLC now owns 97,080 shares of the medical instruments supplier’s stock worth $6,497,000 after acquiring an additional 8,516 shares during the period. Institutional investors and hedge funds own 69.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of Utah Medical Products from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 7th.

Utah Medical Products Stock Performance

Utah Medical Products stock opened at $61.04 on Wednesday. The firm has a market cap of $206.93 million, a price-to-earnings ratio of 15.45 and a beta of 0.08. Utah Medical Products, Inc. has a 1 year low of $58.87 and a 1 year high of $77.33. The firm’s 50 day moving average price is $61.94 and its two-hundred day moving average price is $64.85.

Utah Medical Products (NASDAQ:UTMD) last issued its earnings results on Tuesday, January 28th. The medical instruments supplier reported $0.86 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%.

Utah Medical Products Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 3rd. Shareholders of record on Friday, March 14th will be paid a dividend of $0.305 per share. This represents a $1.22 dividend on an annualized basis and a yield of 2.00%. The ex-dividend date of this dividend is Friday, March 14th. Utah Medical Products’s dividend payout ratio is presently 30.89%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.